Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 1,053,341 |
|
|||||
| News | (1) | ||||||
| Day High | 2.7499 | Low High |
|||||
| Day Low | 2.54 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Taysha Gene Therapies Inc | TSHA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.06 | -2.33% | 2.52 | 23:00:04 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.65 | 2.54 | 2.7499 | 2.57 | 2.58 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,749 | 1,053,341 | US$ 2.64 | US$ 2,776,836 | - | 0.50 - 3.89 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:58:44 | formt | 399 | US$ 2.52 | USD |
Taysha Gene Therapies Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 480.49M | 186.96M | - | 15.45M | -111.57M | -0.60 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Taysha Gene Therapies News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TSHA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.35 | 2.7499 | 2.295 | 2.46 | 1,380,489 | 0.17 | 7.23% |
| 1 Month | 2.66 | 3.40 | 2.165 | 2.71 | 1,857,480 | -0.14 | -5.26% |
| 3 Months | 1.59 | 3.55 | 1.41 | 2.68 | 2,991,546 | 0.93 | 58.49% |
| 6 Months | 2.47 | 3.55 | 1.27 | 2.24 | 2,517,812 | 0.05 | 2.02% |
| 1 Year | 0.74 | 3.89 | 0.50 | 2.29 | 2,685,125 | 1.78 | 240.54% |
| 3 Years | 25.80 | 26.99 | 0.50 | 2.89 | 1,252,626 | -23.28 | -90.23% |
| 5 Years | 22.25 | 33.84 | 0.50 | 3.31 | 1,061,738 | -19.73 | -88.67% |
Taysha Gene Therapies Description
| Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. It is advancing a deep and sustainable product portfolio of 18 gene therapy product candidates, with exclusive options to acquire four additional development programs. Its product candidates include TSHA-101, TSHA-118, TSHA-102, TSHA-103, and TSHA-104. |
